• OPEN AN ACCOUNT
Indian Indices
Sensex
76,672.51 519.65
( 0.68%)
Global Indices
Nasdaq
53,682.77 599.82
(1.13%)
Dow Jones
7,765.55 77.95
(1.01%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,831.87 75.42
(0.70%)
Forex
USD-INR
94.73 -0.22
(-0.23%)
EUR-INR
109.71 -0.40
(-0.36%)
GBP-INR
127.83 -0.65
(-0.50%)
JPY-INR
0.59 0.00
(0.14%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
477.507017
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
16.83
15010.3
EPS(TTM)
Face Value()
Div & Yield %
49.8
2
0.6
 

As on: Sep 04, 2026 01:39 PM

Last Price() Net Change (%) Volume (Nos) P / E
831.10 -6.95 20250 16.83
Stock Price Details
Open Price() 846.95
Best Buy () 830.25
Best Sell () 831.1
Buy Quantity (Nos) 25
Sell Quantity (Nos) 67
Today's High () 846.95
Today's Low () 828.80
52-Week High () 1226.1
152-Week Low () 789.3
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.60
Eps 49.8
Book Value 477.507017
Market Cap (.Cr) 15,010.30
Face Value 2
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE987B01026


News
Natco Pharma to further invest USD 14M in eGenesis Inc.
Stock Alert: Caplin Point Lab, Natco pharma, Federal Bank, B. R. Goyal Infra
Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit
NATCO Pharma's Visakhapatnam unit gets Form 483 with 4 observations from US FDA
Board of Natco Pharma recommends interim dividend
National Aluminium Company Ltd leads losers in 'A' group
Natco Pharma to convene board meeting
NATCO Pharma rallies after USFDA grants tentative approval for Olaparib tablets
Natco Pharma completes acquisition of additional 13.25% stake in Adcock Ingram
NATCO Pharma, Lupin secure USFDA approval for Eribulin Mesylate injection
More
Corporate Details
Incoporation Year   : 1981
Chairman : V C Nannapaneni
Bussiness Group : Natco
Registered Office
Natco Pharma Ltd
Natco House,
Road No 2 Banjara Hills,
Hyderabad,
Telangana-500033
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-040-23547532
Fax:91-040-23548243
Fax:91-22-66317458
E-Mail : investors@natcopharma.co.in
URL : http://www.natcopharma.co.in


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE SmallCap
  • CNX 500
  • CNX SMALLCA
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi